X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (79) 79
humans (72) 72
female (70) 70
breast neoplasms - drug therapy (60) 60
index medicus (59) 59
breast cancer (52) 52
breast neoplasms - pathology (33) 33
trastuzumab (33) 33
chemotherapy (30) 30
breast neoplasms - genetics (25) 25
chemotherapy, adjuvant (25) 25
middle aged (22) 22
adult (20) 20
antineoplastic agents - therapeutic use (20) 20
cancer (20) 20
antineoplastic combined chemotherapy protocols - therapeutic use (18) 18
receptor, erbb-2 - metabolism (18) 18
adjuvant chemotherapy (17) 17
aged (16) 16
treatment outcome (16) 16
disease-free survival (15) 15
antibodies, monoclonal, humanized (14) 14
prognosis (14) 14
breast neoplasms - metabolism (13) 13
care and treatment (13) 13
clinical trials (13) 13
paclitaxel (12) 12
randomized controlled trials as topic (12) 12
tumors (12) 12
antineoplastic agents - adverse effects (11) 11
breast neoplasms - mortality (11) 11
receptor, erbb-2 - genetics (11) 11
survival (11) 11
therapy (11) 11
neoplasm staging (10) 10
open-label (10) 10
research (10) 10
breast neoplasms - therapy (9) 9
doxorubicin (9) 9
gene expression profiling (9) 9
hematology, oncology and palliative medicine (9) 9
her2 (9) 9
medicine & public health (9) 9
medicine, general & internal (9) 9
survival analysis (9) 9
antibodies, monoclonal - therapeutic use (8) 8
antineoplastic agents, hormonal - therapeutic use (8) 8
drug therapy (8) 8
monoclonal-antibody (8) 8
adjuvant treatment (7) 7
biomarkers (7) 7
biomarkers, tumor - genetics (7) 7
cancer therapies (7) 7
clinical trials as topic (7) 7
erbb-2 protein (7) 7
expression (7) 7
follow-up studies (7) 7
gene expression (7) 7
heart failure - chemically induced (7) 7
lapatinib (7) 7
multicenter (7) 7
patients (7) 7
postmenopausal women (7) 7
receptor, erbb-2 - antagonists & inhibitors (7) 7
adjuvant therapy (6) 6
anthracyclines - administration & dosage (6) 6
antibodies, monoclonal, humanized - administration & dosage (6) 6
antibodies, monoclonal, humanized - adverse effects (6) 6
antineoplastic agents (6) 6
antineoplastic agents - administration & dosage (6) 6
breast-cancer (6) 6
cyclophosphamide (6) 6
docetaxel (6) 6
drug administration schedule (6) 6
efficacy (6) 6
follow-up (6) 6
her2-positive breast-cancer (6) 6
international expert consensus (6) 6
metastasis (6) 6
oncology, experimental (6) 6
phase-ii (6) 6
primary therapy (6) 6
proportional hazards models (6) 6
receptor (6) 6
receptor, erbb-2 - analysis (6) 6
recurrence (6) 6
skin and connective tissue diseases (6) 6
surgery (6) 6
tamoxifen (6) 6
analysis (5) 5
antibodies, monoclonal - administration & dosage (5) 5
antimitotic agents (5) 5
biomarkers, tumor - analysis (5) 5
biomarkers, tumor - metabolism (5) 5
breast neoplasms - chemistry (5) 5
combined modality therapy (5) 5
gene expression regulation, neoplastic (5) 5
genes (5) 5
health aspects (5) 5
letrozole (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 07/2014, Volume 32, Issue 20, pp. 2159 - +
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 3, pp. 236 - 244
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2008, Volume 26, Issue 5, pp. 729 - 735
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10075, pp. 1195 - 1205
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9897, pp. 1021 - 1028
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2005, Volume 353, Issue 16, pp. 1659 - 1672
Journal Article